Phase II study of everolimus in patients with metastatic colorectal adenocarcinoma previously treated with bevacizumab-, fluoropyrimidine-, oxaliplatin-, and irinotecan-based regimens (Q37051209)
Jump to navigation
Jump to search
scientific article published on 06 June 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study of everolimus in patients with metastatic colorectal adenocarcinoma previously treated with bevacizumab-, fluoropyrimidine-, oxaliplatin-, and irinotecan-based regimens |
scientific article published on 06 June 2013 |
Statements
1 reference
Phase II study of everolimus in patients with metastatic colorectal adenocarcinoma previously treated with bevacizumab-, fluoropyrimidine-, oxaliplatin-, and irinotecan-based regimens (English)
1 reference
Josep Tabernero
1 reference
Charles S Fuchs
1 reference
Kimmie Ng
1 reference
Jimmy Hwang
1 reference
Emilio Bajetta
1 reference
Sunil Sharma
1 reference
Salvatore A Del Prete
1 reference
Edward R Arrowsmith
1 reference
David P Ryan
1 reference
Michaela Sedova
1 reference
Jin Jin
1 reference
Kamel Malek
1 reference
1 reference
Identifiers
1 reference